Top Markets
Coin of the day
Roche Holding AG Roche Holding AG

Roche Holding AG

RO
Kedudukan dalam Saham #41
Roche Holding AG is a global healthcare enterprise with dual focuses:... Roche Holding AG is a global healthcare enterprise with dual focuses: pharmaceuticals and diagnostics. The company maintains a significant presence in numerous countries, including its home base in Switzerland, alongside Germany, the United States, Austria, the Netherlands, the United Kingdom, France, Belgium, and various other international markets. Its pharmaceutical segment develops and supplies treatments for a wide spectrum of medical conditions, encompassing oncology, neuroscience, infectious diseases, immunology, cardiovascular and metabolic disorders, ophthalmology, and respiratory ailments, as well as specific therapies for anemia, dermatology, hemophilia, inflammatory and autoimmune conditions, and transplant patients. On the diagnostic front, Roche provides in vitro tests designed to identify various diseases like cancer, diabetes, COVID-19, hepatitis, and human papillomavirus, in addition to supplying crucial diagnostic instruments and reagents. The company was founded in Basel, Switzerland, in 1896.
Harga Saham
$459.10
Disegerakkan terakhir: 2026-09-11
Modal Pasaran
$359.91B
Perubahan (1 hari)
0.11%
Perubahan (1 tahun)
30.72%
Negara
CH
Perdagangan Roche Holding AG (RO)

Kategori

Pendapatan untuk Roche Holding AG (RO)
Pendapatan pada Dec 2025 TTM: $21.39B
Menurut laporan kewangan terkini Roche Holding AG, pendapatan semasa syarikat ialah $21.39B. Pada tahun 2024, syarikat memperoleh pendapatan sebanyak $13.06B, penurunan berbanding pendapatan pada tahun 2023 yang berjumlah $16.74B. Pendapatan yang dipaparkan di halaman ini adalah pendapatan sebelum faedah dan cukai atau dikenali sebagai EBIT.
Sejarah pendapatan bagi Roche Holding AG dari 2000 hingga 2026
Pendapatan pada akhir setiap tahun
Tahun Pendapatan Ubah
2026 (TTM) $21.39B 0.00%
2025 $21.39B 63.83%
2024 $13.06B -22.02%
2023 $16.74B -5.44%
2022 $17.70B -7.24%
2021 $19.09B -4.57%
2020 $20.00B 16.46%
2019 $17.17B 19.41%
2018 $14.38B 14.44%
2017 $12.57B -1.66%
2016 $12.78B 6.57%
2015 $11.99B -4.81%
2014 $12.60B -23.40%
2013 $16.45B 22.16%
2012 $13.46B 6.42%
2011 $12.65B 5.47%
2010 $12.00B 21.15%
2009 $9.90B -25.31%
2008 $13.26B -2.09%
2007 $13.54B 31.16%
2006 $10.32B 51.54%
2005 $6.81B -18.34%
2004 $8.34B 111.44%
2003 $3.95B -270.88%
2002 $-2.31B -180.67%
2001 $2.86B -50.86%
2000 $5.82B 0.00%
Pendapatan untuk syarikat atau pesaing serupa
Syarikat Pendapatan Perbezaan Pendapatan Negara
$33.59B 57.07%
US
$25.20B 17.80%
US
$8.70B -59.33%
US
$5.95B -72.19%
US
$16.38B -23.42%
CH